Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Aarti Pharmalabs Ltd, Neogen Chemicals Ltd, Indraprastha Medical Corporation Ltd and Ganesha Ecosphere Ltd are among the other losers in the BSE's 'A' group today, 10 November 2025.
Transformers & Rectifiers India Ltd crashed 20.00% to Rs 314.2 at 14:46 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 3.12 lakh shares were traded on the counter so far as against the average daily volumes of 94684 shares in the past one month.
Aarti Pharmalabs Ltd lost 10.93% to Rs 769.6. The stock was the second biggest loser in 'A' group.On the BSE, 24039 shares were traded on the counter so far as against the average daily volumes of 6785 shares in the past one month.
Neogen Chemicals Ltd tumbled 10.09% to Rs 1307.5. The stock was the third biggest loser in 'A' group.On the BSE, 6252 shares were traded on the counter so far as against the average daily volumes of 2366 shares in the past one month.
Indraprastha Medical Corporation Ltd shed 9.54% to Rs 560.55. The stock was the fourth biggest loser in 'A' group.On the BSE, 55762 shares were traded on the counter so far as against the average daily volumes of 43714 shares in the past one month.
Ganesha Ecosphere Ltd dropped 8.94% to Rs 1052.75. The stock was the fifth biggest loser in 'A' group.On the BSE, 14353 shares were traded on the counter so far as against the average daily volumes of 1147 shares in the past one month.
Profit before tax (PBT) stood at Rs 38.69 crore in Q2 FY26, down 46.09% from Rs 71.77 crore in the same period last year.
Total expenses decreased 2.99% to Rs 379.05 crore in Q2 FY26, compared to Rs 379.05 crore in Q2 FY26. The cost of materials consumed stood at Rs 203.46 crore (down 4.91% YoY), employee benefit expenses were Rs 43.41 crore (up 15.05% YoY) and finance costs stood at Rs 10.67 crore (up 93.64% YoY) during the period under review.
On half-year basis, the company's consolidated net profit climbed 29.64% to Rs 77.45 crore on 20.62% decrease in revenue to Rs 804.53 crore in H1 FY26 over H1 FY25.
Aarti Pharmalabs (APL) is an established, internationally recognized manufacturer of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, new chemical entities (NCEs), and xanthine derivatives based in India.